poisar

Stocks · News reference

8-K filing — KKR & Co. Inc. (KKRS)

SEC EDGAR

Filed: 2026-11-04 AccNo: 0001140361-26-041894 Size: 214 KB Item 7.01: Regulation FD Disclosure

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

KKRS
Source
edgar
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Matt Dilallo

    Why Isn't Realty Income's Stock Taking Off After Strong Earnings Results?

    Realty Income delivered solid Q3 2026 earnings with 3.7% AFFO per share growth, 98.8% occupancy, and a well-covered dividend, but the stock hasn't surged due to modest earnings growth at its large scale. Despite strong operational metrics and a 5.6% dividend yield, the REIT's limited growth potential and interest rate headwinds constrain stock appreciation, though it remains an attractive income investment for steady double-digit returns.

    OKKRKKRSKKRTKKRPD
  2. Patrick Sanders

    Realty Income Has Paid 676 Consecutive Monthly Dividends. Here’s How Its Earnings Results Fit the Bigger Picture.

    Realty Income reported Q3 2026 earnings with AFFO up 3.7% to $1.12 per share and raised full-year guidance to $4.45-$4.46. The REIT maintains a 73% dividend payout ratio, invested $2.6 billion in the quarter at 6.8% yield, and continues its 56-year streak of consecutive monthly dividends supported by a diversified tenant base and 96%+ occupancy rates.

    ODGKKRKKRSKKRT
  3. Na

    Rhythm Pharmaceuticals and LG Chem Enter into Amendment to Bivamelagon Exclusive License Agreement

    Rhythm Pharmaceuticals amended its global licensing agreement with LG Chem for bivamelagon, reducing royalties from low-to-mid-single digits to 1% on MC4R agonist sales while committing to $350 million in fixed payments over four years. The company also secured a $750 million term-loan facility led by KKR's HealthCare Royalty and Blackstone to support the agreement, commercialization efforts, and pipeline development.

    RYTMKKRKKRSKKRTKKRPD
  4. Researchandmarkets.Com

    Global Private Credit and Alternative Lending Market Strategic Report, 2026-2031 | AUM Set to Reach USD 3.36 Trillion as AI Infrastructure and Bank Retrenchment Drive Growth

    The global private credit and alternative lending market is projected to reach USD 3.36 trillion by 2031, growing at 7.8% CAGR from a 2026 base of USD 2.31 trillion. Growth is driven by AI/data-center infrastructure debt, insurance-linked capital, and bank retrenchment, though the market faced liquidity stress in 2025-26 concentrated in retail-facing vehicles, resulting in significant redemption pressures and market capitalization losses for major managers.

    OWLBXBLKDIVBAPO
  5. Not Specified

    Hyperion Materials & Technologies Acquires The Ultra-Met Company

    Hyperion Materials & Technologies has acquired Ultra-Met Company, an Urbana, Ohio-based tungsten carbide manufacturer, to expand its capabilities in serving the US aerospace and defense industries. The acquisition aims to strengthen Western-sourced carbide supply chains and address global supply chain instability for critical defense materials.

    KKRKKRSKKRTKKRPD
  6. Not Specified

    Helix to advance ServiceOps and help enterprises create measurable business value as it completes carve-out from BMC, under Montagu

    Montagu has completed its acquisition of a majority stake in Helix through a carve-out from BMC Software, making Helix a fully independent company. KKR will maintain ownership of BMC and retain a minority stake in Helix. The move aims to give Helix greater focus and flexibility to accelerate growth and innovation in agentic AI ServiceOps solutions.

    HLXCMIHLKKRKKRSKKRT